FDA Unveils AI Platform Elsa

FDA’s AI Platform Elsa Revolutionizes Internal Processes

• The FDA launched the AI platform Elsa to streamline internal operations.
• Elsa reduces document processing time from three days to six minutes.
• The platform operates in a secure GovCloud environment, ensuring data privacy and independence.
• Elsa aligns with the White House’s AI requirements for federal agencies.
• Capabilities include report summarization, drug label comparison, and identifying high-risk facilities.

The FDA’s introduction of Elsa marks a significant advancement in efficiency, cutting document processing from days to minutes while maintaining strict data privacy standards.